ciprofloxacin has been researched along with Infectious Skin Diseases in 34 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bacterial infections of the skin or soft tissue responded to ciprofloxacin 500 mg tablets b." | 9.06 | Bacterial infections of the skin treated with ciprofloxacin. ( Bielunska, S; Gawkonska, M; Gorkiewicz-Petkow, A; Jablonska, S; Petkow, L; Weuta, H, 1988) |
| " A randomized, double-blind, multicenter study was conducted in 492 patients to compare the safety and efficacy of temafloxacin 600 mg with ciprofloxacin 750 mg for the treatment of bacterial infections of the skin or skin structure." | 5.07 | Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin. ( Jungkind, DL; Parish, LC, 1991) |
| "Bacterial infections of the skin or soft tissue responded to ciprofloxacin 500 mg tablets b." | 5.06 | Bacterial infections of the skin treated with ciprofloxacin. ( Bielunska, S; Gawkonska, M; Gorkiewicz-Petkow, A; Jablonska, S; Petkow, L; Weuta, H, 1988) |
| "Ciprofloxacin in a low dosage of 250 mg twice a day was applied in the treatment of bacterial infections of the skin." | 3.67 | [The effectiveness of ciprofloxacin in bacterial skin infections]. ( Blenk, H; Meisel, C, 1988) |
| "Thirty adult patients with severe skin and soft tissue infections (four with contiguous osteomyelitis) caused by a variety of bacterial pathogens were treated with oral ciprofloxacin." | 3.67 | Treatment of skin and soft tissue infections with oral ciprofloxacin. ( Fass, RJ, 1986) |
| "Twenty-one patients with cellulitis or other bacterial soft-tissue infections were treated with oral ciprofloxacin." | 3.67 | Ciprofloxacin for soft tissue infections. ( Logan, MN; Wood, MJ, 1986) |
| "Ciprofloxacin was given as an initial 100 mg twice daily as intravenous infusion, and this was switched to an oral form of 500 mg b." | 2.67 | Ciprofloxacin in severe infections. ( Aswapokee, N; Aswapokee, P; Pruksachatvuthi, S, 1990) |
| "Ciprofloxacin was as effective and safe as ceftazidime for serious infections of the skin and skin structure." | 2.66 | Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure. ( Gentry, LO; Koshdel, A, 1989) |
| " In general, the patients received ciprofloxacin at a dosage of 250 to 750 mg every 12 hours; the median dose was 500 mg twice daily." | 2.66 | Ciprofloxacin: an update on clinical experience. ( Arcieri, G; August, R; Becker, N; Griffith, E; Gruenwaldt, G; Heyd, A; O'Brien, B, 1987) |
| " Blood samples (n = 10) and total urine output were collected during a 24-h dosing interval." | 1.28 | Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections. ( Awni, W; Heim-Duthoy, K; Peltier, G, 1990) |
| "Treatment with ciprofloxacin was very well tolerated." | 1.28 | [Ciprofloxacin treatment in bacterial skin infections]. ( Küchmeister, B; Mohr, CP; Reinel, D; Ulrich, R, 1989) |
| "Ciprofloxacin is an effective and safe therapeutic alternative in many tissue infections caused by susceptible microorganisms." | 1.27 | Open, prospective study of the clinical efficacy of ciprofloxacin. ( Bran, JL; Garcia, JF; Mejia, CR; Ramirez, CA, 1985) |
| "Ciprofloxacin has good activity against gram-positive organisms and excellent activity against gram-negative organisms." | 1.27 | Treatment of cutaneous infections. Worldwide experience with ciprofloxacin. ( Asper, RF; Jungkind, DL; Parish, LC; Witkowski, JA, 1988) |
| "Ciprofloxacin is a new quinolone antimicrobial agent with activity against a broad spectrum of gram-negative and gram-positive organisms, including Pseudomonas aeruginosa and methicillin-resistant strains of staphylococci." | 1.27 | A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial. ( Arcieri, G; August, R; Becker, N; Griffith, E; Gruenwaldt, G; Heyd, A; O'Brien, B; Screen, P, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (58.82) | 18.7374 |
| 1990's | 11 (32.35) | 18.2507 |
| 2000's | 1 (2.94) | 29.6817 |
| 2010's | 2 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Busaidi, I | 1 |
| Wong, D | 1 |
| Boggild, AK | 1 |
| Sevencan, NO | 1 |
| Cakmakliogullari, EK | 1 |
| Ozkan, AE | 1 |
| Kayhan, B | 1 |
| Winthrop, KL | 1 |
| Albridge, K | 1 |
| South, D | 1 |
| Albrecht, P | 1 |
| Abrams, M | 1 |
| Samuel, MC | 1 |
| Leonard, W | 1 |
| Wagner, J | 1 |
| Vugia, DJ | 1 |
| Nichols, RL | 1 |
| Smith, JW | 1 |
| Gentry, LO | 4 |
| Gezon, J | 1 |
| Campbell, T | 1 |
| Sokol, P | 1 |
| Williams, RR | 1 |
| Lipsky, BA | 1 |
| Miller, B | 1 |
| Schwartz, R | 1 |
| Henry, DC | 1 |
| Nolan, T | 1 |
| McCabe, A | 1 |
| Magner, DJ | 1 |
| Talbot, GH | 1 |
| Iakovlev, VP | 1 |
| Parish, LC | 3 |
| Jungkind, DL | 2 |
| McBride, ME | 1 |
| Rudolph, AH | 1 |
| Tschen, JA | 1 |
| Cernoch, P | 1 |
| Davis, J | 1 |
| Brown, BA | 2 |
| Wallace, RJ | 2 |
| Heim-Duthoy, K | 1 |
| Peltier, G | 1 |
| Awni, W | 1 |
| Karimi, K | 1 |
| Aswapokee, N | 1 |
| Pruksachatvuthi, S | 1 |
| Aswapokee, P | 1 |
| Gutknecht, DR | 1 |
| Bedsole, G | 1 |
| Sumter, G | 1 |
| Sanders, CV | 1 |
| Steele, LC | 1 |
| Smith, J | 1 |
| Graham, DR | 1 |
| Thadepalli, H | 2 |
| Mathai, D | 1 |
| Chuah, SK | 1 |
| Bansal, MB | 1 |
| Ramirez-Ronda, CH | 2 |
| Rodriguez-Noriega, E | 2 |
| del Rosal, PL | 1 |
| Ramirez, C | 1 |
| Koshdel, A | 1 |
| Dominguez, J | 1 |
| Palma, F | 1 |
| Vega, ME | 1 |
| Magaña, JL | 1 |
| Ortiz, G | 1 |
| Teresa-Hojyo, M | 1 |
| Dominguez, L | 1 |
| Mohr, CP | 1 |
| Küchmeister, B | 1 |
| Reinel, D | 1 |
| Ulrich, R | 1 |
| Nakamura, S | 1 |
| Minami, A | 1 |
| Nakata, K | 1 |
| Kurobe, N | 1 |
| Kouno, K | 1 |
| Sakaguchi, Y | 1 |
| Kashimoto, S | 1 |
| Yoshida, H | 1 |
| Kojima, T | 1 |
| Ohue, T | 1 |
| Ramirez, CA | 1 |
| Bran, JL | 1 |
| Mejia, CR | 1 |
| Garcia, JF | 1 |
| Meisel, C | 1 |
| Blenk, H | 1 |
| Gorkiewicz-Petkow, A | 1 |
| Weuta, H | 1 |
| Jablonska, S | 1 |
| Petkow, L | 1 |
| Bielunska, S | 1 |
| Gawkonska, M | 1 |
| Ramirez-Ronda, C | 1 |
| Saavedra, S | 2 |
| Witkowski, JA | 1 |
| Asper, RF | 1 |
| Arcieri, G | 2 |
| Griffith, E | 2 |
| Gruenwaldt, G | 2 |
| Heyd, A | 2 |
| O'Brien, B | 2 |
| Screen, P | 1 |
| Becker, N | 2 |
| August, R | 2 |
| Asper, R | 1 |
| Rivera-Vázquez, CR | 1 |
| Pérez-Ruvalcaba, JA | 1 |
| Quintero-Pérez, NP | 1 |
| Morales-Reyes, JJ | 1 |
| Huitrón-Ramírez, JA | 1 |
| Rodríguez-Chagollán, JJ | 1 |
| Greenberg, RN | 1 |
| Kennedy, DJ | 1 |
| Reilly, PM | 1 |
| Luppen, KL | 1 |
| Weinandt, WJ | 1 |
| Bollinger, MR | 1 |
| Aguirre, F | 1 |
| Kodesch, F | 1 |
| Saeed, AM | 1 |
| Neu, HC | 1 |
| Fass, RJ | 1 |
| Wood, MJ | 1 |
| Logan, MN | 1 |
1 review available for ciprofloxacin and Infectious Skin Diseases
| Article | Year |
|---|---|
Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Age | 1992 |
15 trials available for ciprofloxacin and Infectious Skin Diseases
| Article | Year |
|---|---|
Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxac | 1997 |
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Double-Blind Method; Fem | 1999 |
Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ciprofloxac | 1991 |
Clinical experience with ciprofloxacin: analysis of a multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Child; Child, Preschool; Ciproflox | 1990 |
Ciprofloxacin in severe infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Humans; Male; Middle Aged; Pse | 1990 |
Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
Topics: Administration, Oral; Bacterial Infections; Ceftazidime; Ciprofloxacin; Clinical Trials as Topic; Co | 1989 |
Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
Topics: Administration, Oral; Bacterial Infections; Cefotaxime; Ciprofloxacin; Double-Blind Method; Female; | 1989 |
Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
Topics: Administration, Oral; Adult; Aged; Ceftazidime; Ciprofloxacin; Clinical Trials as Topic; Gram-Negati | 1989 |
Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ceftazidime; Ciprofloxacin; Humans; Infusions, Intrav | 1989 |
Bacterial infections of the skin treated with ciprofloxacin.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Female; Humans; Male; Skin Dis | 1988 |
Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study.
Topics: Adult; Bacteria; Cefotaxime; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Female; H | 1987 |
Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
Topics: Administration, Oral; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials as Topi | 1987 |
Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials | 1987 |
Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials | 1987 |
Ciprofloxacin: an update on clinical experience.
Topics: Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Digestive System; Drug Resistance, Mi | 1987 |
18 other studies available for ciprofloxacin and Infectious Skin Diseases
| Article | Year |
|---|---|
Cutaneous Mycobacterium gordonae infection in an elderly diabetic returned traveller.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diagnosis, Differential; Etha | 2017 |
An unusual location of squamous cell carcinoma and a rare cutaneous infection caused by serratia marcescens on the tumoral tissue: A case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Ciprofloxacin; Humans; Male; Sca | 2018 |
The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection.
Topics: Adolescent; Adult; Anti-Infective Agents; Beauty Culture; Ciprofloxacin; Disease Outbreaks; Female; | 2004 |
[Symposium "Ciflozin (ciprofloxacin)--a broad-spectrum antibacterial drug"].
Topics: Bacterial Infections; Ciprofloxacin; Drug Evaluation; Germany, West; Humans; Moscow; Respiratory Tra | 1992 |
Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections.
Topics: Aged; Ciprofloxacin; Female; Forearm; Humans; Mycobacterium; Mycobacterium Infections; Skin Diseases | 1991 |
Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections.
Topics: Adult; Ciprofloxacin; Fleroxacin; Half-Life; Humans; Male; Skin Diseases, Infectious | 1990 |
Treatment of disseminated Mycobacterium chelonae infection with ciprofloxacin.
Topics: Aged; Ciprofloxacin; Humans; Male; Mycobacterium Infections, Nontuberculous; Skin Diseases, Infectio | 1990 |
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
Topics: Adult; Aged; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity | 1990 |
[Ciprofloxacin treatment in bacterial skin infections].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Female; H | 1989 |
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquino | 1989 |
Open, prospective study of the clinical efficacy of ciprofloxacin.
Topics: Adolescent; Adult; Aged; Arthritis; Bacterial Infections; Ciprofloxacin; Female; Gastrointestinal Di | 1985 |
[The effectiveness of ciprofloxacin in bacterial skin infections].
Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Drug Administration Schedule; Erysipelas; | 1988 |
Treatment of cutaneous infections. Worldwide experience with ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Ciprofloxacin; Female; Humans; | 1988 |
A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Humans; Male; Middle Aged; Res | 1988 |
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cellulitis; Ciprofloxacin; Enterob | 1987 |
Ciprofloxacin: an overview and prospective appraisal.
Topics: Administration, Oral; Animals; Bacterial Infections; Ciprofloxacin; Cystic Fibrosis; Disease Models, | 1987 |
Treatment of skin and soft tissue infections with oral ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cellulitis; Ciprofloxacin; Female; | 1986 |
Ciprofloxacin for soft tissue infections.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cellulitis; Ciprofloxacin; Female; Humans; Mal | 1986 |